These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20210988)

  • 21. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.
    Treviño A; Soriano V; Poveda E; Parra P; Cabezas T; Caballero E; Roc L; Rodríguez C; Eiros JM; Lopez M; De Mendoza C;
    J Antimicrob Chemother; 2014 Aug; 69(8):2191-4. PubMed ID: 24788659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
    McGovern RA; Thielen A; Mo T; Dong W; Woods CK; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    AIDS; 2010 Oct; 24(16):2517-25. PubMed ID: 20736814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection.
    Nowak P; Schvarcz R; Ericzon BG; Flamholc L; Sönnerborg A
    AIDS Res Hum Retroviruses; 2003 Jan; 19(1):13-9. PubMed ID: 12581512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein.
    Shimizu N; Haraguchi Y; Takeuchi Y; Soda Y; Kanbe K; Hoshino H
    Virology; 1999 Jul; 259(2):324-33. PubMed ID: 10388657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
    Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function.
    Vecchi M; Burighel N; Bellanova D; Menzo S; De Rossi A; Clementi M; Bagnarelli P
    New Microbiol; 2004 Apr; 27(2 Suppl 1):99-104. PubMed ID: 15646071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.
    Rieder P; Joos B; Scherrer AU; Kuster H; Braun D; Grube C; Niederöst B; Leemann C; Gianella S; Metzner KJ; Böni J; Weber R; Günthard HF
    Clin Infect Dis; 2011 Dec; 53(12):1271-9. PubMed ID: 21998286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1.
    McDonald RA; Chang G; Michael NL
    J Hum Virol; 2001; 4(4):179-87. PubMed ID: 11694845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
    Gorry PR; Dunfee RL; Mefford ME; Kunstman K; Morgan T; Moore JP; Mascola JR; Agopian K; Holm GH; Mehle A; Taylor J; Farzan M; Wang H; Ellery P; Willey SJ; Clapham PR; Wolinsky SM; Crowe SM; Gabuzda D
    Virology; 2007 May; 362(1):163-78. PubMed ID: 17239419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A possible origin of emerged HIV-1 after interrupting anti-retroviral therapy.
    Matsumura J; Shimizu M; Omi K; Nagata N; Shinya E; Oka S; Takahashi H
    Biomed Res; 2014; 35(1):1-8. PubMed ID: 24573196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.
    Briz V; García D; Méndez-Lagares G; Ruiz-Mateos E; de Mulder M; Moreno-Pérez D; Navarro ML; León-Leal JA; de José MI; Ramos JT; Mellado MJ; González-Tomé MI; Leal M; Muñoz-Fernández MA
    Pediatr Infect Dis J; 2012 Oct; 31(10):1048-52. PubMed ID: 22828644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy.
    Bagnarelli P; Vecchi M; Burighel N; Bellanova D; Menzo S; Clementi M; De Rossi A
    AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1306-13. PubMed ID: 15650423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
    N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
    Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
    J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.